In this paper, we explore several neuroprotective genes associated with MS, such as heat shock protein 90 (HSP90), heat shock protein 60 (HSP60), and glial cell line-derived neurotrophic factor (GDNF), emphasizing the evidence that supports their potential as targets for MS therapy. This evidence concerns the gene GDNF and myeloid sarcoma.